Medtronic's Major Merger Fails to Spark Rally on Wall Street

Medtronic's $42.9 billion bid for Covidien highlights a day of acquisitions and mergers on Wall Street.

Jun 16, 2014 at 3:30PM
Longview

Continued merger activity around the world didn't have much of an impact on markets today, and with 30 minutes left in trading the Dow Jones Industrial Average (DJINDICES:^DJI) was down 0.07%.

Siemens and Mitsubishi teamed up to counter General Electric's (NYSE:GE) $17 billion offer for Alstom, which is now a hot commodity among industrial conglomerates. Siemens offered to pay $5.3 billion for Alstom's gas turbine business and proposed joint ventures in rail and power systems. Mitsubishi would take a 10% stake in the French conglomerate and bring more than $4 billion with it. The saga continues, and I wouldn't be shocked to see this be a contested bid all summer.  

But the bigger deal here in the U.S. is Medtronic's (NYSE:MDT) proposed acquisition of Covidien (NYSE:COV), which would bring together two medical device giants.

Why Medtronic has its sights on Covidien
Medtronic's offer of $35.19 in cash and 0.956 shares of ordinary stock for each Covidien share gives the deal a value of $42.9 billion before Medtronic's shares dropped today. But the reason for the deal is even more surprising than the fact that there's another proposed merger in the medical industry.

Mdt Headquarters Image

Medtronic's headquarters in Minneapolis may be a little quieter in coming years. Source: Medtronic.

Medtronic's medical device sales don't necessarily fit well strategically with Covidien's surgical materials business. So many analysts are pointing to the tax benefits of the acquisition as the key.  

Covidien's headquarters are in Ireland, and Medtronic plans to move its own headquarters there once the deal is finalized. That will free up international profit to be returned to HQ in the new country, whereas many companies keep cash abroad so they can avoid repatriation taxes in the U.S. That tax benefit was also a planned benefit of Pfizer's recent attempts to acquire British pharmaceutical AstraZeneca

The Medtronic buy could also free up cash to spend on further acquisitions and research. But before we go assuming the best for this merger, keep in mind that larger mergers or acquisitions rarely add the kind of value management expects over the long term. For that reason, it's worth looking at skeptically from Medtronic's side.

There's also the possibility that U.S. tax law is put under so much pressure that rules are changed and make the tax benefits moot. It will take years to determine if the deal is a success, but it's worth noting that taxes are now a huge consideration of major U.S. corporations, which are even willing to move abroad to save money.

Will this stock be your next multibagger?
Give us five minutes and we'll show how you could own the best stock for 2014. Every year, The Motley Fool's chief investment officer hand-picks one stock with outstanding potential. But it's not just any run-of-the-mill company. It's a stock perfectly positioned to cash in on one of the upcoming year's most lucrative trends. Last year his pick skyrocketed 134%. And previous top picks have gained upwards of 908%, 1,252% and 1,303% over the subsequent years! Believe me, you don't want to miss what could be his biggest winner yet! Just click here to download your free copy of "The Motley Fool's Top Stock for 2014" today.

Travis Hoium manages an account that owns shares of General Electric Company. The Motley Fool recommends Covidien. The Motley Fool owns shares of General Electric Company and Medtronic. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Money to your ears - A great FREE investing resource for you

The best way to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as “binge-worthy finance.”

Feb 1, 2016 at 5:03PM

Whether we're in the midst of earnings season or riding out the market's lulls, you want to know the best strategies for your money.

And you'll want to go beyond the hype of screaming TV personalities, fear-mongering ads, and "analysis" from people who might have your email address ... but no track record of success.

In short, you want a voice of reason you can count on.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich," rated The Motley Fool as the #1 place online to get smarter about investing.

And one of the easiest, most enjoyable, most valuable ways to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as "binge-worthy finance."

Whether you make it part of your daily commute or you save up and listen to a handful of episodes for your 50-mile bike rides or long soaks in a bubble bath (or both!), the podcasts make sense of your money.

And unlike so many who want to make the subjects of personal finance and investing complicated and scary, our podcasts are clear, insightful, and (yes, it's true) fun.

Our free suite of podcasts

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. The show is also heard weekly on dozens of radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable. Rule Breaker Investing and Answers are timeless, so it's worth going back to and listening from the very start; the other three are focused more on today's events, so listen to the most recent first.

All are available for free at www.fool.com/podcasts.

If you're looking for a friendly voice ... with great advice on how to make the most of your money ... from a business with a lengthy track record of success ... in clear, compelling language ... I encourage you to give a listen to our free podcasts.

Head to www.fool.com/podcasts, give them a spin, and you can subscribe there (at iTunes, Stitcher, or our other partners) if you want to receive them regularly.

It's money to your ears.

 


Compare Brokers